About Solute carrier family 67 member A2
Solute carrier family 67 member A2 (SLC67A2) is a protein
from Homo sapiens identified by UniProt accession
Q8NBP5, 474 residues long.
MolForge cross-references it against 0 known binders and
14 disease associations.
Target properties
| Protein name | Solute carrier family 67 member A2 |
| UniProt accession | Q8NBP5 |
| Gene | SLC67A2 |
| Organism | Homo sapiens |
| Length | 474 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (14)
Diseases linked to this target (Open Targets).
- testosterone measurement · score 0.43
- electrocardiography · score 0.18
- alcohol consumption measurement · score 0.15
- PR interval · score 0.15
- self reported educational attainment · score 0.09
- eosinophil count · score 0.09
- ST2 protein measurement · score 0.07
- eosinophilic esophagitis · score 0.06
- neurofibrillary tangles measurement · score 0.06
- Inhalant adrenergic use measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NBP5-F1 | alphafold | PREDICTED | 81.06 | — |
Amino-acid sequence (474 residues)
MELGGHWDMN SAPRLVSETA ERKQEQKTGT EAEAADSGAV GARRFLLCLY LVGFLDLFGV SMVVPLLSLH VKSLGASPTV AGIVGSSYGI LQLFSSTLVG CWSDVVGRRS SLLACILLSA LGYLLLGAAT NVFLFVLARV PAGIFKHTLS ISRALLSDVV PEKERPLVIG HFNTASGVGF ILGPVVGGYL TELEDGFYLT AFICFLVFIL NAGLVWFFPW REAKPGSTEK GLPLRKTHVL LGRSHDTVQE AATSRRARAS KKTAQPWVEV VLALRNMKNL LFSEMWDIFL VRLLMAMAVM LYYSNFVLAL EERFGVRPKV TGYLISYSSM LGAVAGLALG PILRLYKHNS QALLLHSSIL TCTLLLLYSL APTMGAVVLS STLLSFSTAI GRTCITDLQL TVGGAQASGT LIGVGQSVTA VGRIIAPLLS GVAQEVSPCG PPSLGAVLAL VAIFIMSLNK RHSSGDGNSK LKSE
Explore Solute carrier family 67 member A2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets